The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Generic Injection Market Research Report 2025
Synopsis
Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
The global Generic Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Generic Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injection.
Report Scope
The Generic Injection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Injection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Segment by Type
Liquid Injection
Powder for Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Injection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Generic injections are injections that have the same active ingredients, the same dosage, the same route of administration, the same dosage form, and the same indications as the original drug.
The global Generic Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Generic Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Generic Injection.
Report Scope
The Generic Injection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Generic Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Generic Injection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
Fresenius
Viatris
Pfizer
Teva Pharmaceuticals
Hikma Pharmaceuticals
Novartis
Amneal Pharmaceuticals
Gland Pharma
Allergan
Kelun Pharmaceutical
Jiangsu HRS
Qilu Pharmaceutical
Chiatai Tianqing
Hainan Poly Pharm
Yangzijiang Pharmaceutical Industry
Shijiazhuang Pharma Group
Segment by Type
Liquid Injection
Powder for Injection
Segment by Application
Hospital
Clinic
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Generic Injection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Generic Injection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Liquid Injection
1.2.3 Powder for Injection
1.3 Market by Application
1.3.1 Global Generic Injection Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Generic Injection Market Perspective (2019-2030)
2.2 Generic Injection Growth Trends by Region
2.2.1 Global Generic Injection Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Generic Injection Historic Market Size by Region (2019-2024)
2.2.3 Generic Injection Forecasted Market Size by Region (2025-2030)
2.3 Generic Injection Market Dynamics
2.3.1 Generic Injection Industry Trends
2.3.2 Generic Injection Market Drivers
2.3.3 Generic Injection Market Challenges
2.3.4 Generic Injection Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Generic Injection Players by Revenue
3.1.1 Global Top Generic Injection Players by Revenue (2019-2024)
3.1.2 Global Generic Injection Revenue Market Share by Players (2019-2024)
3.2 Global Generic Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Generic Injection Revenue
3.4 Global Generic Injection Market Concentration Ratio
3.4.1 Global Generic Injection Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Generic Injection Revenue in 2023
3.5 Generic Injection Key Players Head office and Area Served
3.6 Key Players Generic Injection Product Solution and Service
3.7 Date of Enter into Generic Injection Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Generic Injection Breakdown Data by Type
4.1 Global Generic Injection Historic Market Size by Type (2019-2024)
4.2 Global Generic Injection Forecasted Market Size by Type (2025-2030)
5 Generic Injection Breakdown Data by Application
5.1 Global Generic Injection Historic Market Size by Application (2019-2024)
5.2 Global Generic Injection Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Generic Injection Market Size (2019-2030)
6.2 North America Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Generic Injection Market Size by Country (2019-2024)
6.4 North America Generic Injection Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Generic Injection Market Size (2019-2030)
7.2 Europe Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Generic Injection Market Size by Country (2019-2024)
7.4 Europe Generic Injection Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Generic Injection Market Size (2019-2030)
8.2 Asia-Pacific Generic Injection Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Generic Injection Market Size by Region (2019-2024)
8.4 Asia-Pacific Generic Injection Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Generic Injection Market Size (2019-2030)
9.2 Latin America Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Generic Injection Market Size by Country (2019-2024)
9.4 Latin America Generic Injection Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Generic Injection Market Size (2019-2030)
10.2 Middle East & Africa Generic Injection Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Generic Injection Market Size by Country (2019-2024)
10.4 Middle East & Africa Generic Injection Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Generic Injection Introduction
11.1.4 Sanofi Revenue in Generic Injection Business (2019-2024)
11.1.5 Sanofi Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Detail
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Generic Injection Introduction
11.2.4 Fresenius Revenue in Generic Injection Business (2019-2024)
11.2.5 Fresenius Recent Development
11.3 Viatris
11.3.1 Viatris Company Detail
11.3.2 Viatris Business Overview
11.3.3 Viatris Generic Injection Introduction
11.3.4 Viatris Revenue in Generic Injection Business (2019-2024)
11.3.5 Viatris Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Generic Injection Introduction
11.4.4 Pfizer Revenue in Generic Injection Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Teva Pharmaceuticals
11.5.1 Teva Pharmaceuticals Company Detail
11.5.2 Teva Pharmaceuticals Business Overview
11.5.3 Teva Pharmaceuticals Generic Injection Introduction
11.5.4 Teva Pharmaceuticals Revenue in Generic Injection Business (2019-2024)
11.5.5 Teva Pharmaceuticals Recent Development
11.6 Hikma Pharmaceuticals
11.6.1 Hikma Pharmaceuticals Company Detail
11.6.2 Hikma Pharmaceuticals Business Overview
11.6.3 Hikma Pharmaceuticals Generic Injection Introduction
11.6.4 Hikma Pharmaceuticals Revenue in Generic Injection Business (2019-2024)
11.6.5 Hikma Pharmaceuticals Recent Development
11.7 Novartis
11.7.1 Novartis Company Detail
11.7.2 Novartis Business Overview
11.7.3 Novartis Generic Injection Introduction
11.7.4 Novartis Revenue in Generic Injection Business (2019-2024)
11.7.5 Novartis Recent Development
11.8 Amneal Pharmaceuticals
11.8.1 Amneal Pharmaceuticals Company Detail
11.8.2 Amneal Pharmaceuticals Business Overview
11.8.3 Amneal Pharmaceuticals Generic Injection Introduction
11.8.4 Amneal Pharmaceuticals Revenue in Generic Injection Business (2019-2024)
11.8.5 Amneal Pharmaceuticals Recent Development
11.9 Gland Pharma
11.9.1 Gland Pharma Company Detail
11.9.2 Gland Pharma Business Overview
11.9.3 Gland Pharma Generic Injection Introduction
11.9.4 Gland Pharma Revenue in Generic Injection Business (2019-2024)
11.9.5 Gland Pharma Recent Development
11.10 Allergan
11.10.1 Allergan Company Detail
11.10.2 Allergan Business Overview
11.10.3 Allergan Generic Injection Introduction
11.10.4 Allergan Revenue in Generic Injection Business (2019-2024)
11.10.5 Allergan Recent Development
11.11 Kelun Pharmaceutical
11.11.1 Kelun Pharmaceutical Company Detail
11.11.2 Kelun Pharmaceutical Business Overview
11.11.3 Kelun Pharmaceutical Generic Injection Introduction
11.11.4 Kelun Pharmaceutical Revenue in Generic Injection Business (2019-2024)
11.11.5 Kelun Pharmaceutical Recent Development
11.12 Jiangsu HRS
11.12.1 Jiangsu HRS Company Detail
11.12.2 Jiangsu HRS Business Overview
11.12.3 Jiangsu HRS Generic Injection Introduction
11.12.4 Jiangsu HRS Revenue in Generic Injection Business (2019-2024)
11.12.5 Jiangsu HRS Recent Development
11.13 Qilu Pharmaceutical
11.13.1 Qilu Pharmaceutical Company Detail
11.13.2 Qilu Pharmaceutical Business Overview
11.13.3 Qilu Pharmaceutical Generic Injection Introduction
11.13.4 Qilu Pharmaceutical Revenue in Generic Injection Business (2019-2024)
11.13.5 Qilu Pharmaceutical Recent Development
11.14 Chiatai Tianqing
11.14.1 Chiatai Tianqing Company Detail
11.14.2 Chiatai Tianqing Business Overview
11.14.3 Chiatai Tianqing Generic Injection Introduction
11.14.4 Chiatai Tianqing Revenue in Generic Injection Business (2019-2024)
11.14.5 Chiatai Tianqing Recent Development
11.15 Hainan Poly Pharm
11.15.1 Hainan Poly Pharm Company Detail
11.15.2 Hainan Poly Pharm Business Overview
11.15.3 Hainan Poly Pharm Generic Injection Introduction
11.15.4 Hainan Poly Pharm Revenue in Generic Injection Business (2019-2024)
11.15.5 Hainan Poly Pharm Recent Development
11.16 Yangzijiang Pharmaceutical Industry
11.16.1 Yangzijiang Pharmaceutical Industry Company Detail
11.16.2 Yangzijiang Pharmaceutical Industry Business Overview
11.16.3 Yangzijiang Pharmaceutical Industry Generic Injection Introduction
11.16.4 Yangzijiang Pharmaceutical Industry Revenue in Generic Injection Business (2019-2024)
11.16.5 Yangzijiang Pharmaceutical Industry Recent Development
11.17 Shijiazhuang Pharma Group
11.17.1 Shijiazhuang Pharma Group Company Detail
11.17.2 Shijiazhuang Pharma Group Business Overview
11.17.3 Shijiazhuang Pharma Group Generic Injection Introduction
11.17.4 Shijiazhuang Pharma Group Revenue in Generic Injection Business (2019-2024)
11.17.5 Shijiazhuang Pharma Group Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Generic Injection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Liquid Injection
Table 3. Key Players of Powder for Injection
Table 4. Global Generic Injection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Generic Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Generic Injection Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Generic Injection Market Share by Region (2019-2024)
Table 8. Global Generic Injection Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Generic Injection Market Share by Region (2025-2030)
Table 10. Generic Injection Market Trends
Table 11. Generic Injection Market Drivers
Table 12. Generic Injection Market Challenges
Table 13. Generic Injection Market Restraints
Table 14. Global Generic Injection Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Generic Injection Market Share by Players (2019-2024)
Table 16. Global Top Generic Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injection as of 2023)
Table 17. Ranking of Global Top Generic Injection Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Generic Injection Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Generic Injection Product Solution and Service
Table 21. Date of Enter into Generic Injection Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Generic Injection Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Generic Injection Revenue Market Share by Type (2019-2024)
Table 25. Global Generic Injection Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Generic Injection Revenue Market Share by Type (2025-2030)
Table 27. Global Generic Injection Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Generic Injection Revenue Market Share by Application (2019-2024)
Table 29. Global Generic Injection Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Generic Injection Revenue Market Share by Application (2025-2030)
Table 31. North America Generic Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Generic Injection Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Generic Injection Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Generic Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Generic Injection Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Generic Injection Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Generic Injection Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Generic Injection Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Generic Injection Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Generic Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Generic Injection Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Generic Injection Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Generic Injection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Generic Injection Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Generic Injection Market Size by Country (2025-2030) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Generic Injection Product
Table 49. Sanofi Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Fresenius Company Detail
Table 52. Fresenius Business Overview
Table 53. Fresenius Generic Injection Product
Table 54. Fresenius Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 55. Fresenius Recent Development
Table 56. Viatris Company Detail
Table 57. Viatris Business Overview
Table 58. Viatris Generic Injection Product
Table 59. Viatris Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 60. Viatris Recent Development
Table 61. Pfizer Company Detail
Table 62. Pfizer Business Overview
Table 63. Pfizer Generic Injection Product
Table 64. Pfizer Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 65. Pfizer Recent Development
Table 66. Teva Pharmaceuticals Company Detail
Table 67. Teva Pharmaceuticals Business Overview
Table 68. Teva Pharmaceuticals Generic Injection Product
Table 69. Teva Pharmaceuticals Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 70. Teva Pharmaceuticals Recent Development
Table 71. Hikma Pharmaceuticals Company Detail
Table 72. Hikma Pharmaceuticals Business Overview
Table 73. Hikma Pharmaceuticals Generic Injection Product
Table 74. Hikma Pharmaceuticals Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 75. Hikma Pharmaceuticals Recent Development
Table 76. Novartis Company Detail
Table 77. Novartis Business Overview
Table 78. Novartis Generic Injection Product
Table 79. Novartis Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 80. Novartis Recent Development
Table 81. Amneal Pharmaceuticals Company Detail
Table 82. Amneal Pharmaceuticals Business Overview
Table 83. Amneal Pharmaceuticals Generic Injection Product
Table 84. Amneal Pharmaceuticals Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 85. Amneal Pharmaceuticals Recent Development
Table 86. Gland Pharma Company Detail
Table 87. Gland Pharma Business Overview
Table 88. Gland Pharma Generic Injection Product
Table 89. Gland Pharma Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 90. Gland Pharma Recent Development
Table 91. Allergan Company Detail
Table 92. Allergan Business Overview
Table 93. Allergan Generic Injection Product
Table 94. Allergan Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 95. Allergan Recent Development
Table 96. Kelun Pharmaceutical Company Detail
Table 97. Kelun Pharmaceutical Business Overview
Table 98. Kelun Pharmaceutical Generic Injection Product
Table 99. Kelun Pharmaceutical Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 100. Kelun Pharmaceutical Recent Development
Table 101. Jiangsu HRS Company Detail
Table 102. Jiangsu HRS Business Overview
Table 103. Jiangsu HRS Generic Injection Product
Table 104. Jiangsu HRS Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 105. Jiangsu HRS Recent Development
Table 106. Qilu Pharmaceutical Company Detail
Table 107. Qilu Pharmaceutical Business Overview
Table 108. Qilu Pharmaceutical Generic Injection Product
Table 109. Qilu Pharmaceutical Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 110. Qilu Pharmaceutical Recent Development
Table 111. Chiatai Tianqing Company Detail
Table 112. Chiatai Tianqing Business Overview
Table 113. Chiatai Tianqing Generic Injection Product
Table 114. Chiatai Tianqing Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 115. Chiatai Tianqing Recent Development
Table 116. Hainan Poly Pharm Company Detail
Table 117. Hainan Poly Pharm Business Overview
Table 118. Hainan Poly Pharm Generic Injection Product
Table 119. Hainan Poly Pharm Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 120. Hainan Poly Pharm Recent Development
Table 121. Yangzijiang Pharmaceutical Industry Company Detail
Table 122. Yangzijiang Pharmaceutical Industry Business Overview
Table 123. Yangzijiang Pharmaceutical Industry Generic Injection Product
Table 124. Yangzijiang Pharmaceutical Industry Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 125. Yangzijiang Pharmaceutical Industry Recent Development
Table 126. Shijiazhuang Pharma Group Company Detail
Table 127. Shijiazhuang Pharma Group Business Overview
Table 128. Shijiazhuang Pharma Group Generic Injection Product
Table 129. Shijiazhuang Pharma Group Revenue in Generic Injection Business (2019-2024) & (US$ Million)
Table 130. Shijiazhuang Pharma Group Recent Development
Table 131. Research Programs/Design for This Report
Table 132. Key Data Information from Secondary Sources
Table 133. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Generic Injection Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Generic Injection Market Share by Type: 2023 VS 2030
Figure 3. Liquid Injection Features
Figure 4. Powder for Injection Features
Figure 5. Global Generic Injection Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Generic Injection Market Share by Application: 2023 VS 2030
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Generic Injection Report Years Considered
Figure 11. Global Generic Injection Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Generic Injection Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Generic Injection Market Share by Region: 2023 VS 2030
Figure 14. Global Generic Injection Market Share by Players in 2023
Figure 15. Global Top Generic Injection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Generic Injection as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Generic Injection Revenue in 2023
Figure 17. North America Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Generic Injection Market Share by Country (2019-2030)
Figure 19. United States Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Generic Injection Market Share by Country (2019-2030)
Figure 23. Germany Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Generic Injection Market Share by Region (2019-2030)
Figure 31. China Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Generic Injection Market Share by Country (2019-2030)
Figure 39. Mexico Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Generic Injection Market Share by Country (2019-2030)
Figure 43. Turkey Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Generic Injection Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Sanofi Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 46. Fresenius Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 47. Viatris Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 50. Hikma Pharmaceuticals Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 51. Novartis Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 52. Amneal Pharmaceuticals Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 53. Gland Pharma Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 54. Allergan Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 55. Kelun Pharmaceutical Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 56. Jiangsu HRS Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 57. Qilu Pharmaceutical Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 58. Chiatai Tianqing Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 59. Hainan Poly Pharm Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 60. Yangzijiang Pharmaceutical Industry Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 61. Shijiazhuang Pharma Group Revenue Growth Rate in Generic Injection Business (2019-2024)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
